Brain Scanning Articles & Analysis
18 news found
In the future, we hope this type of biomarker response will help predict a therapeutic benefit long before clinical benefits can be measured.” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) ...
Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, adds the potential for more precise and objective brain scan analysis. Qynapse’s predictive AI technology, QyPredict®, available for research-use-only, has the potential to predict disease trajectory and improve targeted patient selection in clinical trials. ...
ByQynapse
The posters highlight Qynapse’s latest results with QyScore®, its commercially-available automated brain image analysis platform, demonstrating the reproducibility of its results and its value to inform the MS diagnostic standard. ...
ByQynapse
Qynapse will demo its flagship FDA-cleared and CE-marked neuroimaging solution, QyScore®, which combines MRI scans and AI to produce rapid, actionable insights into CNS disorders, such as Alzheimer’s disease, multiple sclerosis and Parkinson’s disease. ...
ByQynapse
Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, combines MRI scans and artificial intelligence to produce rapid, actionable insights into CNS disorders, adding the potential for more precise and objective brain scan analysis. ...
ByQynapse
It provides a quick, non-invasive and objective aid to diagnosis, providing a low-cost alternative to brain scans. The improved accuracy over other solutions provides advantages – in particular for measuring response to dopaminergic medication. ...
Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting Drug Controller General of India (DCGI) and Health Canada grant permission to conduct clinical trial at multiple sites in India and Canada Current standard of care lacks a means to monitor ...
However, regular MRI images are of limited use in the differential diagnosis of dementia or estimating its severity as they don’t show enough detail. Brain MRI scans are currently used to rule out other neurodegenerative diseases rather than directly diagnose the cause of dementia and do not help in early diagnosis. ...
Ongoing or repeat bleeding in the brain contributes to decreased brain function and disability and may be difficult to detect under the current standard of care. There is currently no objective way to detect brain injury and stroke subtype in a field environment, or to continuously monitor brain injury for expanded hemorrhage in ...
Neurosurgery procedures are extremely complex requiring high precision to avoid damage to vital structures of the brain. Neuronavigation systems help to guide surgeons to perform an even more accurate surgery, decreasing the percentage of serious damage to these vital structures. ...
ByAxial3D
More than 400,000 military personnel have suffered at least one traumatic brain injury in the last two decades. Long-term consequences for patients may have been better if doctors could more quickly have diagnosed the situation and treated it. Now there appears to be a solution and it involves the Norwood company Sense Neuro Diagnostics. ...
Sense Neuro Diagnostics, founded in 2014 by four University of Cincinnati physicians, said the $2.43 million, 18-month award from the U.S. Department of Defense will accelerate development of a new rapid, noninvasive brain scanner that can detect and continuously monitor traumatic brain injury in a battlefield or field environment. TBI, for short, is a signature wound of recent wars. There have ...
” Each year nearly 800,000 people suffer strokes in the United States and 1.7 million Americans suffer traumatic brain injury. Ongoing or repeat bleeding in the brain contributes to decreased brain function and disability and may be difficult to detect under the current standard of care. There is currently no objective way to detect ...
Dr Steven Chance, CEO, Oxford Brain Diagnostics said ‘we are very excited to be working with our partners and the NIHR on this project. ...
If some of the many thousands of human volunteers needed to test coronavirus vaccines could have been replaced by digital replicas—one of this year’s Top 10 Emerging Technologies—COVID-19 vaccines might have been developed even faster, saving untold lives. Soon virtual clinical trials could be a reality for testing new vaccines and therapies. Other technologies on the list ...
CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate assessment of the neurodegeneration associated with Alzheimer’s disease and other dementias. ...
“Data is the fuel for AI, and Evoke has generated a cross-sectional database of over 58,000 computational EEG brain scans. This means Evoke has an exceptional vantage point to develop insights into EEG data interpretation that can be useful in novel diagnostic approaches,” said Neil Sahota. “I’m excited to be a part of Evoke Neuroscience ...
Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of ...
ByGE Power